Fundraising Fox

ProteoNova

Pasadena, US · California corporation

ProteoNova is a biotechnology company that developed the Accelerated Protein Evolution Technology (AcPET) System, a platform for synthesizing proteins for a wide range of purposes. The company positions the technology as a faster and lower-cost alternative to other protein synthesis methods.

BiotechDeep Tech

Founders & leadership

RBRichard B. Williams
Richard B. WilliamsExecutive
RR
Robert R. GuerreroExecutive

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 2 rounds · 2017–2018

▶$1.5MraisedFeb 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard B. WilliamsExecutive Officer, Director
  • Robert R. GuerreroExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$1.5M
Proceeds to insiders
$76.4K
First sale
Jan 2018
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$95KraisedFeb 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard B. WilliamsExecutive Officer, Director
  • Robert R. GuerreroExecutive Officer, Director
Offering amount
$1.4M
Amount sold
$95K
Minimum investment
$25K
First sale
Oct 2017
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does ProteoNova do?
ProteoNova is a biotechnology company that developed the Accelerated Protein Evolution Technology (AcPET) System, a platform for synthesizing proteins for a wide range of purposes. The company positions the technology as a faster and lower-cost alternative to other protein synthesis methods.
How much funding has ProteoNova raised?
ProteoNova has disclosed $1.6M raised across 2 rounds.
Where is ProteoNova headquartered?
ProteoNova is headquartered in Pasadena, US.